HIGHLIGHTS
- who: Report et al. from the (UNIVERSITY) have published the article: Review began 11/18/2022 Review ended 11/23/2022 Published 11/25/2022 u00a9 Copyright, in the Journal: (JOURNAL) of November/25,/2022
- what: Long-term TKI use may predispose CML patients to the development of secondary lymphomas, treatment for iatrogenic lymphoma is on the same lines as de-novo lymphoma, however, more research is needed as data is inconclusive.
- future: Long-term TKI use may predispose CML patients to the development of secondary lymphomas treatment for iatrogenic lymphoma is on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.